Literature DB >> 6227745

Low dose glucocorticoid therapy in rheumatoid arthritis (RA): transitional or selected add-on therapy?

A T Masi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6227745

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

1.  Corticosteroid can alter antigen expression on alveolar macrophages.

Authors:  L Marianayagam; L W Poulter
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

2.  Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing.

Authors:  A T Masi; G P Chrousos
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

3.  Short course of synacthen therapy as an adjunct in the management of rheumatoid arthritis.

Authors:  E Ben-Chetrit; Y Naparstek; M Ehrenfeld; M Eliakim
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

4.  Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.

Authors:  P N Sambrook; J A Eisman; M G Yeates; N A Pocock; S Eberl; G D Champion
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

5.  Corticosteroid prescribing in rheumatoid arthritis and psoriatic arthritis.

Authors:  W Grassi; R De Angelis; C Cervini
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

6.  Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study.

Authors:  P N Sambrook; M L Cohen; J A Eisman; N A Pocock; G D Champion; M G Yeates
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.